Last reviewed · How we verify
pentoxyphylline
At a glance
| Generic name | pentoxyphylline |
|---|---|
| Also known as | Oxopurin, Trental, Pentoxifylline-Teva |
| Sponsor | Meir Medical Center |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Phase I, Dose-Escalation Clinical Trial to Evaluate the Safety and Tolerability of Pentoxifylline PKB171 Gel in Single-Dose Intravaginal Administration, Followed by an Extension Study With Multiple-Do (Phase 1)
- Evaluation of the Clinical Benefit of a Spa Care on the Evolution of Late Fibrosis After Postoperative Radiotherapy for Breast Cancer in Remission (Phase 3)
- Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy (NA)
- Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients (NA)
- Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome: A Pilot Study (Phase 2)
- Pentoxifylline, Atorvastatin, and Vitamin E (PAVE) as Treatment for Radiation-Induced Erectile Dysfunction (Phase 2)
- The Effects of Pentoxifylline on PAI-1 in an Obese Population (Phase 4)
- A Phase II Study of the Use of Pentoxifylline and a-Tocopherol in the Treatment of Chronic Breast Pain Associated With Breast Radiotherapy (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pentoxyphylline CI brief — competitive landscape report
- pentoxyphylline updates RSS · CI watch RSS
- Meir Medical Center portfolio CI